biotech · Non-Small Cell Lung Cancer · Pneumococcal Vaccines · MAIA
MAIA Biotechnology
MAIA Biotechnology trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
honolulu, USA HQ
2013 Founded
5 Employees
Public company Type
MAIA · NYSE Ticker
Company details
- Status
- Public
- HQ
- honolulu, USA
- Founded
- 2013
- Employees
- 5
- Programs
- 8
- Drugs
- 19
- Patents
- 10
MAIA Biotechnology clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to MAIA Biotechnology programs — each row shows trial ID, program name, phase, status, and indication.
MAIA Biotechnology trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for MAIA Biotechnology.
-
THIO-101 — Phase 2
Clinical update -
THIO-104 — Phase 3
Clinical update -
etrasimod — Phase 2
Clinical update -
Blood ponction — Unknown
Clinical update -
12-Valent Pneumococcal Conjugate Vaccine — Phase 3
Clinical update -
6-Thio-2'-Deoxyguanosine — Phase 3
Clinical update -
Fecal Microbiota Transplant (FMT) — Phase 1
Clinical update -
ateganosine — Phase 1
Clinical update